IRVINE, Calif., Nov. 29, 2006 (PRIME NEWSWIRE) -- The informational report "Putting the Fizz Back in the Beverage Market" has been made available free of charge at www.SmallCapSentinel.com and will address preeminent and emerging sports beverage companies such as Coca-Cola (NYSE:KO) which produces Powerade, PepsiCo (NYSE:PEP) which makes Gatorade, Millennium Biotechnologies, Inc.,(OTCBB:MBTG) who makes Resurgex, and PacificHealth Laboratories Inc. (OTCBB:PHLI) which markets Accelerade.
"The beverage market is liquid to say the least, and in the highly scrutinized arena of sports drinks and recovery beverages, enhancements matter most," said SmallCap Sentinel analyst D.R. Clark. "Science-driven innovation in the sports drink industry, vetted on the playing field as well as the laboratory, can lead to enormous success in the consumer market if positioned properly."
"Perhaps this opens a door for Millennium Biotechnologies, Inc. which recently announced preliminary results of its second double blind, placebo controlled clinical trial that found its Resurgex(r) nutritional formula provided improvements in strength (Wingate testing) and increased lean muscle gain while reducing body fat in Rutgers University Division 1 football players (strength athletes). The preliminary results showed Resurgex(r) outperformed a leading sports nutritional formula commonly used by athletes," Clark noted.
A detailed report regarding Millennium Biotechnologies, Inc. is available free to the investing public at the following link:
http://stockupticks.com/profiles/11-28-06.html
Millennium Biotechnologies, Inc. is a wholly owned subsidiary of Millennium Biotechnologies Group, Inc. MBTG is a research-based nutraceutical company and a pioneer in the emerging field of specialized nutritional supplements. MBTG's flagship products include: RESURGEX(r), RESURGEX Plus(tm), and RESURGEX Select(tm), and are designed to assist in reducing fatigue and oxidative stress, maintaining lean muscle, and immune support in immunocompromised conditions.
Individuals may also register to receive future reports on emergent public companies at:
http://stockupticks.com/register.html
To be featured in SmallCap Sentinel or StockUpTicks.com please use the contact information below or email sts@marketpathways.com
Statements made herein contain forward-looking statements and are subject to significant risks and uncertainties that affect results. SmallCap Sentinel and StockUpTicks.com are properties of Market Pathways Financial Relations Inc. (MP). MP provides no assurance as to the subject company's plans or ability to effect any proposed actions and cannot project its capabilities, intent, resources, or experience.
All information contained herein is based upon sources believed to be reliable but no representation is made as to its accuracy or completeness. This report is neither a solicitation to buy nor an offer to sell securities but is rather a paid advertisement provided for information purposes only and should not be used as the basis for any investment decision. MP is not an investment advisor and this report is not investment advice. MP has been paid $24,000 by Millennium Biotechnologies, Inc. for preparation and distribution of this report and other advertising services over a ninety day period. This constitutes a conflict of interest as to MP's ability to remain objective in its communication regarding subject companies.